Thrivent Financial For Lutherans Relay Therapeutics, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 160,458 shares of RLAY stock, worth $819,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,458
Previous 120,011
33.7%
Holding current value
$819,940
Previous $782,000
45.4%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
203Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$143 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$73.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$53.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$47.3 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$37.7 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $614M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...